XML 35 R24.htm IDEA: XBRL DOCUMENT v3.21.2
Note 7 - Stock-based Compensation (Details Textual)
$ in Millions
9 Months Ended
Sep. 30, 2021
USD ($)
shares
Share-based Payment Arrangement, Option [Member]  
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total | $ $ 1.9
Panbela Therapeutics, Inc. 2016 Omnibus Incentive Plan [Member]  
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year) 10 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance (in shares) 2,257,136
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in shares) 1,328,363
Panbela Therapeutics, Inc. 2016 Omnibus Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member]  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance (in shares) 16,185
Panbela Therapeutics, Inc. 2011 Stock Option Plan [Member]  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance (in shares) 232,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term (Year) 3 years 2 months 12 days